Keyphrases
1,2,3-Triazol
9%
AKAP150
9%
Alzheimer's Disease
46%
Alzheimer's Disease Model
13%
AMPA Receptor (AMPAR)
17%
AMPA Receptor Endocytosis
9%
Amyloid beta
10%
Amyloid-β Peptide
12%
Apoptosis
10%
Biological Evaluation
11%
Brain Diseases
9%
Cerebral Amyloid Angiopathy
23%
Cerebral Ischemia
27%
Cerebrovascular Disease
18%
Disease-based
11%
Endothelial Cells
10%
Executor
9%
GluA1
13%
Hemorrhagic Stroke
9%
Immunohistochemical Study
9%
Long-term Depression
15%
Membrane Binding
10%
Monoamine Oxidase A (MAO-A)
12%
Monoamine Oxidase B (MAO-B)
11%
Monoamine Oxidase B Inhibitors
9%
Monoaminergic
9%
Mouse Brain
11%
N-methylation
9%
Neurodegeneration
18%
Neurological Outcome
10%
Neuropathology
10%
Oxidase Activity
36%
Oxygen-glucose Deprivation
20%
Protective Behavior
10%
Protective Effect
11%
Radiometric Methods
9%
Retina
13%
Semicarbazide-sensitive Amine Oxidase
100%
Stricter Regulation
9%
Stroke Disease
13%
Synapse Dysfunction
9%
Synaptic Plasticity
11%
Therapeutic Approaches
11%
Therapeutic Effect
10%
Tissue Plasminogen Activator (t-PA)
9%
Transepithelial Electrical Resistance
9%
Transgenic Mouse Model
21%
Vascular Adhesion protein-1 (VAP-1)
90%
Vascular Amyloid
19%
Vascular Cells
13%
Neuroscience
Alzheimer's Disease
59%
Amine Oxidase (Copper Containing)
75%
AMPA Receptor
17%
Amyloid Protein
15%
Amyloidosis
10%
Apolipoprotein A
9%
B Cell
9%
Blood Plasma
22%
Brain Disease
9%
Brain Ischemia
36%
Caspase
9%
Cell Line
12%
Cerebral Amyloid Angiopathy
18%
Cerebral Cortex
9%
Cerebral Hemorrhage
19%
Cerebrovascular Accident
60%
Cerebrovascular Disease
9%
Cholinergic
9%
Cognitive Disorders
12%
Diabetes Mellitus
14%
Endocytosis
9%
Enzyme Activity
7%
Gliosis
9%
In Vitro
21%
Lactoferrin
9%
Leukocyte
10%
Long-Term Depression
6%
Monoamine
9%
Monoamine Oxidase
6%
Mucin 1
6%
Neurodegeneration
11%
Notch
9%
Oligomer
9%
Parkinson's Disease
6%
Photoreceptor Cell
11%
Polyunsaturated Fatty Acid
9%
Propionic Acid
9%
Protein Expression
11%
Protein S
6%
Receptor
9%
Retina S Antigen
9%
Simvastatin
9%
Small Cytoplasmic RNA
5%
Sodium Bicarbonate
9%
Synapse
9%
Theobromine
9%
Tissue Plasminogen Activator
9%
Vascular Adhesion Protein 1
81%
Vascular Disease
9%
XIAP
9%
Medicine and Dentistry
Alpha Tocopherol
9%
Alzheimer's Disease
29%
Amine Oxidase (Copper-Containing)
57%
Amine Oxidase (Flavin Containing)
5%
Amyloid Beta
9%
Amyloid Protein
5%
Antioxidant
6%
Apoplexy
42%
B Lymphocyte
9%
Blood Vessel Tone
9%
Brain Disease
9%
Brain Ischemia
20%
Catecholaminergic System
9%
Cerebral Hemorrhage
9%
Cerebrovascular Disease
9%
Cholinergic System
9%
Cognitive Defect
12%
Diseases
11%
Endothelial Cell
10%
Enzyme Activity
6%
In Vitro
9%
Leukocyte
5%
Medicine
6%
Methylamine
6%
Monoamine
9%
Monoaminergic System
9%
Parkinson's Disease
6%
Pathophysiology
5%
Polyphenol
9%
Polyunsaturated Fatty Acid
9%
Programmed Cell Death
9%
Side Effect
6%
Theobromine
9%
Tissue Plasminogen Activator
9%
Vanilloid Receptor 2
9%
Vascular Adhesion Protein 1
11%
Vascular Adhesion Protein-1
44%
Vascular Cell Line
9%
Vascular Disease
9%
Vascular Smooth Muscle Cell
9%
